MORE►
UT Southwestern Medical Center
UNTHSC Interim President Kirk A. Calhoun, MD, FACP [Photos: UNTHSC]
UNTHSC Announces Former UT Tyler President as Its Interim President
by Lance Murray | Feb 5, 2025
Dr. Kirk Calhoun was named interim president following the resignation in January of UNTHSC President Sylvia Trent-Adams.
by Lance Murray |
Nov 12, 2024
Each $50,000 Early-Stage Research Grant helps fuel critically important medical and scientific research in North Texas. To date, the 21 researchers supported by The Cary Council have gone on to secure more than $21 million in additional funding.
MORE►
by Lance Murray |
Oct 2, 2024
Children's Health and UT Soutwestern announced that a $100 million gift from The Rees-Jones Foundation will support the construction of the new pediatric campus, just months after the Jean and Mack Pogue family gave its own $100 million gift. This marks the first time in Texas that a not-for-profit construction project has received two individual leadership gifts of $100 million.
MORE►
by Quincy Preston |
Aug 9, 2024
With a new CEO and three seasoned industry veterans joining its board, Research Bridge Partners is focused on moving university innovations from the lab to the marketplace.
Last year, the Texas-based nonprofit, in collaboration with Lyda Hill Philanthropies, invested $4 million into North Texas’ UT Southwestern Medical Center, bolstering efforts to transform groundbreaking research into viable companies.
Last year, the Texas-based nonprofit, in collaboration with Lyda Hill Philanthropies, invested $4 million into North Texas’ UT Southwestern Medical Center, bolstering efforts to transform groundbreaking research into viable companies.
MORE►
UT Southwestern's Clements University Hospital [Photo: UTSW]
UTSW Partners on Study That Could Lead to Earlier Detection of Ovarian Cancer
by Lance Murray | Jun 17, 2024
Researchers at Children's Hospital of Philadelphia and UT Southwestern analyzed T-cell receptors in nearly 500 blood samples from pre-diagnostic patients with ovarian cancer. The results point to the potential of testing for biomarkers 2 to 4 years before most cases of HGOC are currently diagnosed.
MORE►
by Lance Murray |
May 22, 2024
The UT Southwestern researchers' noninvasive model uses a standard MRI, paired with machine learning AI, to detect the presence of cancer cells in the lymph nodes under the arms.
MORE►
by Lance Murray |
May 3, 2024
Thomas W. Dubensky Jr., Ph.D., is a veteran biopharma executive and entrepreneur with a track record of strategic leadership in both private and public companies, ImmuneSensor said.
MORE►
by Glenn Hunter |
May 2, 2024
Dallas Innovates, the Dallas Regional Chamber, and Dallas AI have teamed up to launch the inaugural AI 75 list. The 2024 program honors the most significant people in AI in DFW in seven categories—the visionaries, creators, and influencers you need to know.
MORE►
[Image: istockphoto; DI Studio]
Dallas Trio To Bring ‘Specialists to Patients’ With Rural Cardiac Telemedicine Pilot
by Lance Murray | Mar 6, 2024
With support from the American Heart Association, Access TeleCare and UT Southwestern Medical Center are spearheading a two-year initiative aimed at improving cardiac care for rural patients.
MORE►
by Quincy Preston |
Mar 5, 2024
According to a new report from Dallas-based JLL, society is accelerating the volume of data it creates at a rapid rate—and that data is foundational to how we work, live, and play. That's led to sharply increasing demand for data centers in a time of tightening supply, forcing a shift toward secondary and new, emerging markets.
MORE►
by Lance Murray |
Feb 27, 2024
Included in the 12 Dallas-area funding awards is a $4 million Rising Star grant to bring Stefan Gloeggler, Ph.D., to UT Southwestern Medical Center from the Max Planck Institute of Multidisciplinary Sciences in Göttingen, Germany.
MORE►
by Lance Murray |
Feb 13, 2024
UT Southwestern Medical Center and pharmaceutical company Pfizer have teamed up to develop new ways to deliver genetic treatments to patients.
Together they aim to accelerate the development of therapies that work through RNA biology and engineered delivery methods to fix root genetic causes of disease, which Pfizer could apply to its portfolio of investigational programs.
Together they aim to accelerate the development of therapies that work through RNA biology and engineered delivery methods to fix root genetic causes of disease, which Pfizer could apply to its portfolio of investigational programs.
MORE►
Vincent Tagliabracci, PhD [Photo: UTSWMC]
UTSW Professor to Receive O’Donnell Award in Biological Sciences
by Lance Murray | Jan 15, 2024
Molecular biologist Vincent Tagliabracci, who was named a Howard Hughes Medical Institute Investigator in 2021, will be honored by the Texas Academy of Medicine, Engineering, Science and Technology for his groundbreaking work on so-called zombie enzymes.
MORE►
by Lance Murray |
Dec 30, 2023
Researchers at Dallas’ UT Southwestern Medical Center are leading three multicenter clinical trials focused on potential treatment for methamphetamine or cocaine addiction that are funded by the National Institute on Drug Abuse (NIDA)....
MORE►
by Lance Murray |
Nov 20, 2023
The research could lead to new ways to study the human brain without influence from other bodily functions. Also, it could inform the design of machines for cardiopulmonary bypass that better replicate natural blood flow to the brain.
MORE►
by Quincy Preston |
Nov 2, 2023
The new on-campus facility at the University of Arlington will be a major upgrade in research infrastructure for the Texas Tier One institution. A focus of the new center will be pressing issues in brain health.
MORE►
